Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in Heart

Retrieve available abstracts of 244 articles:
HTML format

Single Articles

    July 2021
  1. FUKAYA H, Ako J, Yasuda S, Kaikita K, et al
    Aspirin versus P2Y12 inhibitors with anticoagulation therapy for atrial fibrillation.
    Heart. 2021 Jul 14. pii: heartjnl-2021-319321. doi: 10.1136/heartjnl-2021-319321
    PubMed     Abstract available

  2. IMBERTI JF, Ding WY, Kotalczyk A, Zhang J, et al
    Catheter ablation as first-line treatment for paroxysmal atrial fibrillation: a systematic review and meta-analysis.
    Heart. 2021 Jul 14. pii: heartjnl-2021-319496. doi: 10.1136/heartjnl-2021-319496
    PubMed     Abstract available

  3. PHILLIPS K, Subramanian A, Thomas GN, Khan N, et al
    Trends in the pharmacological management of atrial fibrillation in UK general practice 2008-2018.
    Heart. 2021 Jul 5. pii: heartjnl-2021-319338. doi: 10.1136/heartjnl-2021-319338.
    PubMed     Abstract available

    June 2021
  4. CHEN TH, Chu YC, Ou SM, Tarng DC, et al
    Associations of atrial fibrillation with renal function decline in patients with chronic kidney disease.
    Heart. 2021 Jun 30. pii: heartjnl-2021-319297. doi: 10.1136/heartjnl-2021-319297
    PubMed     Abstract available

  5. MULDER BA, Rienstra M, Van Gelder IC, Blaauw Y, et al
    Update on management of atrial fibrillation in heart failure: a focus on ablation.
    Heart. 2021 Jun 4. pii: heartjnl-2020-318081. doi: 10.1136/heartjnl-2020-318081.
    PubMed     Abstract available

  6. SANZ-GARCIA A, Cecconi A, Vera A, Camarasaltas JM, et al
    Electrocardiographic biomarkers to predict atrial fibrillation in sinus rhythm electrocardiograms.
    Heart. 2021 Jun 4. pii: heartjnl-2021-319120. doi: 10.1136/heartjnl-2021-319120.
    PubMed     Abstract available

    May 2021
  7. WILDE AAM, Amin AS, Postema PG
    Diagnosis, management and therapeutic strategies for congenital long QT syndrome.
    Heart. 2021 May 26. pii: heartjnl-2020-318259. doi: 10.1136/heartjnl-2020-318259
    PubMed     Abstract available

  8. KAWAJI T, Ogawa H, Hamatani Y, Kato M, et al
    Association of inverted T wave during atrial fibrillation rhythm with subsequent cardiac events.
    Heart. 2021 May 26. pii: heartjnl-2021-319199. doi: 10.1136/heartjnl-2021-319199
    PubMed     Abstract available

  9. NICOLI CD, O'Neal WT, Levitan EB, Singleton MJ, et al
    Atrial fibrillation and risk of incident heart failure with reduced versus preserved ejection fraction.
    Heart. 2021 May 24. pii: heartjnl-2021-319122. doi: 10.1136/heartjnl-2021-319122
    PubMed     Abstract available

  10. ELVAN A
    It's all about improvement of quality of life and reduction of disease burden in atrial fibrillation ablation.
    Heart. 2021 May 20. pii: heartjnl-2021-319382. doi: 10.1136/heartjnl-2021-319382

  11. BOSMAN LP, Te Riele ASJM
    Arrhythmogenic right ventricular cardiomyopathy: a focused update on diagnosis and risk stratification.
    Heart. 2021 May 14. pii: heartjnl-2021-319113. doi: 10.1136/heartjnl-2021-319113
    PubMed     Abstract available

  12. CHOI Y, Lee Y, Kim SH, Kim S, et al
    Single direct oral anticoagulant therapy in stable patients with atrial fibrillation beyond 1 year after coronary stent implantation.
    Heart. 2021 May 14. pii: heartjnl-2020-318750. doi: 10.1136/heartjnl-2020-318750
    PubMed     Abstract available

  13. GUPTA D, Ding WY
    Contemporary management of persistent atrial fibrillation.
    Heart. 2021 May 14. pii: heartjnl-2020-317422. doi: 10.1136/heartjnl-2020-317422

  14. CHUA W, Fabritz L
    Heart failure in patients with atrial fibrillation: why it matters now more than ever.
    Heart. 2021 May 13. pii: heartjnl-2021-319145. doi: 10.1136/heartjnl-2021-319145

  15. RUTHERFORD OW, Jonasson C, Ghanima W, Soderdahl F, et al
    Effectiveness and safety of oral anticoagulants in elderly patients with atrial fibrillation.
    Heart. 2021 May 11. pii: heartjnl-2020-318753. doi: 10.1136/heartjnl-2020-318753
    PubMed     Abstract available

  16. GUPTA D, Vijgen J, Potter T, Scherr D, et al
    Quality of life and healthcare utilisation improvements after atrial fibrillation ablation.
    Heart. 2021 May 5. pii: heartjnl-2020-318676. doi: 10.1136/heartjnl-2020-318676.
    PubMed     Abstract available

    April 2021
  17. SANTOS IS, Bensenor IM
    Cardiovascular health and atrial fibrillation.
    Heart. 2021 Apr 15. pii: heartjnl-2021-319253. doi: 10.1136/heartjnl-2021-319253

  18. LEE JH, Yang PS, Yu HT, Kim TH, et al
    Association of cardiovascular health and incident atrial fibrillation in elderly population.
    Heart. 2021 Apr 2. pii: heartjnl-2020-318858. doi: 10.1136/heartjnl-2020-318858.
    PubMed     Abstract available

    March 2021
  19. MELDUNI R, Nkomo VT, Wysokinski W, Gersh BJ, et al
    Risk of left atrial appendage thrombus and stroke in patients with atrial fibrillation and mitral regurgitation.
    Heart. 2021 Mar 25. pii: heartjnl-2020-317659. doi: 10.1136/heartjnl-2020-317659
    PubMed     Abstract available

  20. WEBER C, Hung J, Hickling S, Nedkoff L, et al
    Incidence, predictors and mortality risk of new heart failure in patients hospitalised with atrial fibrillation.
    Heart. 2021 Mar 11. pii: heartjnl-2020-318648. doi: 10.1136/heartjnl-2020-318648
    PubMed     Abstract available

  21. BUNTING KV, Gill SK, Sitch A, Mehta S, et al
    Improving the diagnosis of heart failure in patients with atrial fibrillation.
    Heart. 2021 Mar 10. pii: heartjnl-2020-318557. doi: 10.1136/heartjnl-2020-318557
    PubMed     Abstract available

  22. GUASCH E
    Natriuretic peptides in atrial fibrillation: evidence is here, but are we ready to go one step beyond?
    Heart. 2021 Mar 9. pii: heartjnl-2020-318335. doi: 10.1136/heartjnl-2020-318335.

  23. WOZNIAK O, Borowiec K, Konka M, Cicha-Mikolajczyk A, et al
    Implantable cardiac defibrillator events in patients with arrhythmogenic right ventricular cardiomyopathy.
    Heart. 2021 Mar 4. pii: heartjnl-2020-318415. doi: 10.1136/heartjnl-2020-318415.
    PubMed     Abstract available

    February 2021
  24. LOWRES N, Giskes K, Freedman B
    Next frontier in management of atrial fibrillation.
    Heart. 2021 Feb 23. pii: heartjnl-2021-318961. doi: 10.1136/heartjnl-2021-318961

    January 2021
  25. KORNEJ J, Benjamin EJ, Magnani JW
    Atrial fibrillation: global burdens and global opportunities.
    Heart. 2021 Jan 28. pii: heartjnl-2020-318480. doi: 10.1136/heartjnl-2020-318480

  26. DU X, Guo L, Xia S, Du J, et al
    Atrial fibrillation prevalence, awareness and management in a nationwide survey of adults in China.
    Heart. 2021 Jan 28. pii: heartjnl-2020-317915. doi: 10.1136/heartjnl-2020-317915
    PubMed     Abstract available

  27. PELLEGRINI CN, Buzkova P, Lichtenstein AH, Matthan NR, et al
    Individual non-esterified fatty acids and incident atrial fibrillation late in life.
    Heart. 2021 Jan 22. pii: heartjnl-2020-317929. doi: 10.1136/heartjnl-2020-317929
    PubMed     Abstract available

  28. PAK HN, Park JW, Yang SY, Kim M, et al
    Sex differences in mapping and rhythm outcomes of a repeat atrial fibrillation ablation.
    Heart. 2021 Jan 22. pii: heartjnl-2020-318282. doi: 10.1136/heartjnl-2020-318282
    PubMed     Abstract available

  29. OTTO CM
    Heartbeat: increased use of NOACs in patients with atrial fibrillation reduces health care system costs by reducing stroke incidence.
    Heart. 2021;107:1-3.

  30. SINGH T, Newby DE
    Is the fear of disease worse than the disease itself?
    Heart. 2021;107:91-92.

    December 2020
  31. LOWRES N, Giskes K, Freedman B
    Next frontier for stroke prevention in atrial fibrillation: ensuring anticoagulant persistence.
    Heart. 2020 Dec 23. pii: heartjnl-2020-318392. doi: 10.1136/heartjnl-2020-318392

  32. GARCIA RODRIGUEZ LA, Cea Soriano L, Munk Hald S, Hallas J, et al
    Discontinuation of oral anticoagulation in atrial fibrillation and risk of ischaemic stroke.
    Heart. 2020 Dec 11. pii: heartjnl-2020-317887. doi: 10.1136/heartjnl-2020-317887
    PubMed     Abstract available

  33. HANON O, Vidal JS, Pisica-Donose G, Orvoen G, et al
    Bleeding risk with rivaroxaban compared with vitamin K antagonists in patients aged 80 years or older with atrial fibrillation.
    Heart. 2020 Dec 1. pii: heartjnl-2020-317923. doi: 10.1136/heartjnl-2020-317923.
    PubMed     Abstract available

    November 2020
  34. CIPRIANI A, Bauce B
    Ventricular arrhythmias in mitral valve prolapse: new explanations for an old problem.
    Heart. 2020 Nov 25. pii: heartjnl-2020-318086. doi: 10.1136/heartjnl-2020-318086

  35. HAMATANI Y, Iguchi M, Ueno K, Aono Y, et al
    Prognostic significance of natriuretic peptide levels in atrial fibrillation without heart failure.
    Heart. 2020 Nov 20. pii: heartjnl-2020-317735. doi: 10.1136/heartjnl-2020-317735
    PubMed     Abstract available

  36. WANG L, Ze F, Li J, Mi L, et al
    Trends of global burden of atrial fibrillation/flutter from Global Burden of Disease Study 2017.
    Heart. 2020 Nov 4. pii: heartjnl-2020-317656. doi: 10.1136/heartjnl-2020-317656.
    PubMed     Abstract available

    October 2020
  37. ORLOWSKI A, Gale CP, Ashton R, Petrungaro B, et al
    Clinical and budget impacts of changes in oral anticoagulation prescribing for atrial fibrillation.
    Heart. 2020 Oct 28. pii: heartjnl-2020-317006. doi: 10.1136/heartjnl-2020-317006
    PubMed     Abstract available

  38. BARRA S, Providencia R
    Anticoagulation in atrial fibrillation.
    Heart. 2020 Oct 28. pii: heartjnl-2020-316728. doi: 10.1136/heartjnl-2020-316728

  39. BOYLE PM, Del Alamo JC, Akoum N
    Fibrosis, atrial fibrillation and stroke: clinical updates and emerging mechanistic models.
    Heart. 2020 Oct 23. pii: heartjnl-2020-317455. doi: 10.1136/heartjnl-2020-317455
    PubMed     Abstract available

  40. ALMORAD A, Ohanyan A, Pintea Bentea G, Wielandts JY, et al
    D-dimer blood concentrations to exclude left atrial thrombus in patients with atrial fibrillation.
    Heart. 2020 Oct 21. pii: heartjnl-2020-317612. doi: 10.1136/heartjnl-2020-317612
    PubMed     Abstract available

  41. MIDDELDORP ME, Gupta A, Elliott A, Kadhim K, et al
    Cessation of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.
    Heart. 2020 Oct 16. pii: heartjnl-2020-317418. doi: 10.1136/heartjnl-2020-317418
    PubMed     Abstract available

  42. PICCINI JP, Todd DM, Massaro T, Lougee A, et al
    Changes in quality of life, cognition and functional status following catheter ablation of atrial fibrillation.
    Heart. 2020 Oct 12. pii: heartjnl-2020-316612. doi: 10.1136/heartjnl-2020-316612
    PubMed     Abstract available

  43. SRIDHAR AR, Colbert R
    Quality of life after atrial fibrillation ablation: measuring the most important end-point.
    Heart. 2020 Oct 12. pii: heartjnl-2020-317547. doi: 10.1136/heartjnl-2020-317547

  44. HECKMAN L, Vijayaraman P, Luermans J, Stipdonk AMW, et al
    Novel bradycardia pacing strategies.
    Heart. 2020 Oct 7. pii: heartjnl-2020-316849. doi: 10.1136/heartjnl-2020-316849.
    PubMed     Abstract available

    Atrial fibrillation in heart failure with preserved ejection fraction: a risk marker, risk factor or confounder?
    Heart. 2020 Oct 5. pii: heartjnl-2020-317978. doi: 10.1136/heartjnl-2020-317978.

  46. VAN WIJNGAARDEN AL, de Riva M, Hiemstra YL, van der Bijl P, et al
    Parameters associated with ventricular arrhythmias in mitral valve prolapse with significant regurgitation.
    Heart. 2020 Oct 1. pii: heartjnl-2020-317451. doi: 10.1136/heartjnl-2020-317451.
    PubMed     Abstract available

  47. PFIRMAN KS, Dawson Dowe J, Gaba D
    Man in his 70s with fatigue, dyspnoea and recurrent atrial fibrillation.
    Heart. 2020;106:1572-1619.

    September 2020
  48. CARNICELLI AP, Al-Khatib SM, Xavier D, Dalgaard F, et al
    Premature permanent discontinuation of apixaban or warfarin in patients with atrial fibrillation.
    Heart. 2020 Sep 16. pii: heartjnl-2020-317229. doi: 10.1136/heartjnl-2020-317229
    PubMed     Abstract available

  49. CHU G, Valerio L, van der Wall SJ, Barco S, et al
    Tailoring anticoagulant treatment of patients with atrial fibrillation using a novel bleeding risk score.
    Heart. 2020 Sep 9. pii: heartjnl-2019-316305. doi: 10.1136/heartjnl-2019-316305.
    PubMed     Abstract available

  50. IHSAN J, Khand A, Adlan AM
    Ventricular storm following late presentation acute myocardial infarction.
    Heart. 2020;106:1399-1448.

    August 2020
  51. KJERPESETH LJ, Igland J, Selmer R, Ellekjaer H, et al
    Prevalence and incidence rates of atrial fibrillation in Norway 2004-2014.
    Heart. 2020 Aug 20. pii: heartjnl-2020-316624. doi: 10.1136/heartjnl-2020-316624
    PubMed     Abstract available

  52. MAEDA T, Nishi T, Funakoshi S, Tada K, et al
    Residual risks of ischaemic stroke and systemic embolism among atrial fibrillation patients with anticoagulation: large-scale real-world data (F-CREATE project).
    Heart. 2020 Aug 14. pii: heartjnl-2020-317299. doi: 10.1136/heartjnl-2020-317299
    PubMed     Abstract available

  53. HENDRIKS J, Gallagher C, Nyfort-Hansen K, Lau D, et al
    Adherence to anticoagulation therapy in patients with atrial fibrillation: is a tailored team-based approach warranted?
    Heart. 2020 Aug 7. pii: heartjnl-2020-317478. doi: 10.1136/heartjnl-2020-317478.

    July 2020
  54. DING WY, Gupta D, Lip GYH
    Atrial fibrillation and the prothrombotic state: revisiting Virchow's triad in 2020.
    Heart. 2020 Jul 16. pii: heartjnl-2020-316977. doi: 10.1136/heartjnl-2020-316977
    PubMed     Abstract available

  55. LYCKHAGE LF, Hansen ML, Toft JC, Larsen SL, et al
    Continuous electrocardiography for detecting atrial fibrillation beyond 1 year after stroke in primary care.
    Heart. 2020 Jul 3. pii: heartjnl-2020-316904. doi: 10.1136/heartjnl-2020-316904.
    PubMed     Abstract available

    June 2020
  56. ROSANO G, Savarese G
    Inter-twinned relationship between heart failure and atrial fibrillation.
    Heart. 2020 Jun 1. pii: heartjnl-2020-316886. doi: 10.1136/heartjnl-2020-316886.

    May 2020
  57. AL SAID S, Katus HA, Alabed S
    Cochrane corner: NOACs in atrial fibrillation patients post-percutaneous coronary intervention.
    Heart. 2020 May 29. pii: heartjnl-2020-316726. doi: 10.1136/heartjnl-2020-316726

  58. WONG KC, Klimis H, Lowres N, von Huben A, et al
    Diagnostic accuracy of handheld electrocardiogram devices in detecting atrial fibrillation in adults in community versus hospital settings: a systematic review and meta-analysis.
    Heart. 2020 May 11. pii: heartjnl-2020-316611. doi: 10.1136/heartjnl-2020-316611
    PubMed     Abstract available

  59. KIM WK, Kim HJ, Kim JB, Jung SH, et al
    Exclusion versus preservation of the left atrial appendage in rheumatic mitral valve surgery.
    Heart. 2020 May 6. pii: heartjnl-2019-316387. doi: 10.1136/heartjnl-2019-316387.
    PubMed     Abstract available

  60. OTTO CM
    Heartbeat: smartwatch devices for detection of atrial fibrillation.
    Heart. 2020;106:627-628.

  61. SHAH RL, Badhwar N
    Approach to narrow complex tachycardia: non-invasive guide to interpretation and management.
    Heart. 2020;106:772-783.

    April 2020
  62. SON MK, Park JJ, Lim NK, Kim WH, et al
    Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction.
    Heart. 2020 Apr 27. pii: heartjnl-2019-316219. doi: 10.1136/heartjnl-2019-316219
    PubMed     Abstract available

  63. GASPARINI M, Kloppe A, Lunati M, Varma N, et al
    Sex differences in implantable cardiac defibrillator therapy according to arrhythmia detection times.
    Heart. 2020;106:520-526.
    PubMed     Abstract available

  64. THOMAS MR, Grove EL, Kirchhof P
    Complex antithrombotic combinations: how to find the perfect blend?
    Heart. 2020;106:557-558.

    March 2020
  65. KRISAI P, Blum S, Aeschbacher S, Beer JH, et al
    Associations of symptoms and quality of life with outcomes in patients with atrial fibrillation.
    Heart. 2020 Mar 31. pii: heartjnl-2019-316314. doi: 10.1136/heartjnl-2019-316314
    PubMed     Abstract available

  66. LAROSA AR, Claxton J, O'Neal WT, Lutsey PL, et al
    Association of household income and adverse outcomes in patients with atrial fibrillation.
    Heart. 2020 Mar 6. pii: heartjnl-2019-316065. doi: 10.1136/heartjnl-2019-316065.
    PubMed     Abstract available

  67. MOSS AJ, Jordan A, Carpenter JP
    Seventy-one-year-old man with transient left bundle branch block.
    Heart. 2020;106:386-398.

  68. YAO X, Noseworthy P
    NOAC dosing and monitoring: really as simple as it seems?
    Heart. 2020;106:321-322.

    February 2020
  69. LUPERCIO F, Giancaterino S, Villablanca PA, Han F, et al
    P2Y12 inhibitors with oral anticoagulation for percutaneous coronary intervention with atrial fibrillation: a systematic review and meta-analysis.
    Heart. 2020 Feb 7. pii: heartjnl-2019-315963. doi: 10.1136/heartjnl-2019-315963.
    PubMed     Abstract available

  70. WESTERMANN D, Schrage B
    Mitral stenosis and atrial fibrillation.
    Heart. 2020 Feb 6. pii: heartjnl-2019-316282. doi: 10.1136/heartjnl-2019-316282.

  71. KIM JY, Kim SH, Myong JP, Choi Y, et al
    Ten-year trends in the incidence, treatment and outcomes of patients with mitral stenosis in Korea.
    Heart. 2020 Feb 6. pii: heartjnl-2019-315883. doi: 10.1136/heartjnl-2019-315883.
    PubMed     Abstract available

  72. DIAMANTINO AC, Nascimento BR, Beaton AZ, Nunes MCP, et al
    Atrial fibrillation detection with a portable device during cardiovascular screening in primary care.
    Heart. 2020 Feb 4. pii: heartjnl-2019-316277. doi: 10.1136/heartjnl-2019-316277.
    PubMed     Abstract available

  73. BRUIKMAN C, de Ronde MWJ, Amin A, Levy S, et al
    Sudden cardiac death in families with premature cardiovascular disease.
    Heart. 2020;106:228-232.
    PubMed     Abstract available

  74. KAMAKURA T, Shinohara T, Yodogawa K, Murakoshi N, et al
    Long-term prognosis of patients withJ-wave syndrome.
    Heart. 2020;106:299-306.
    PubMed     Abstract available

    January 2020
  75. NELSON AJ, Patel MR
    Ischaemic stroke in heart failure: back to basics?
    Heart. 2020 Jan 27. pii: heartjnl-2019-315957. doi: 10.1136/heartjnl-2019-315957

  76. TAN TC, Nunes MCP, Handschumacher M, Pontes-Neto O, et al
    Left atrial cross-sectional area is a novel measure of atrial shape associated with cardioembolic strokes.
    Heart. 2020 Jan 24. pii: heartjnl-2019-315964. doi: 10.1136/heartjnl-2019-315964
    PubMed     Abstract available

    Diagnosing atrial fibrillation by mobile technology: physician decision or device provision?
    Heart. 2020 Jan 23. pii: heartjnl-2019-316390. doi: 10.1136/heartjnl-2019-316390

  78. MISTRY A, Vali Z, Sidhu B, Budgeon C, et al
    Disparity in implantable cardioverter defibrillator therapy among minority South Asians in the United Kingdom.
    Heart. 2020 Jan 10. pii: heartjnl-2019-315978. doi: 10.1136/heartjnl-2019-315978
    PubMed     Abstract available

  79. RAJAKARIAR K, Koshy AN, Sajeev JK, Nair S, et al
    Accuracy of a smartwatch based single-lead electrocardiogram device in detection of atrial fibrillation.
    Heart. 2020 Jan 7. pii: heartjnl-2019-316004. doi: 10.1136/heartjnl-2019-316004.
    PubMed     Abstract available

  80. INOHARA T, Holmes DN, Pieper K, Blanco RG, et al
    Decline in renal function and oral anticoagulation dose reduction among patients with atrial fibrillation.
    Heart. 2020 Jan 7. pii: heartjnl-2019-315792. doi: 10.1136/heartjnl-2019-315792.
    PubMed     Abstract available

  81. MUTLUER FO, Canpolat U, Yap SC
    Premature ventricular contraction-induced cardiomyopathy entails more than only systolic left ventricular dysfunction.
    Heart. 2020;106:164.

    December 2019
  82. UEBERHAM L, Konig S, Hohenstein S, Mueller-Roething R, et al
    Sex differences of resource utilisation and outcomes in patients with atrial arrhythmias and heart failure.
    Heart. 2019 Dec 19. pii: heartjnl-2019-315566. doi: 10.1136/heartjnl-2019-315566
    PubMed     Abstract available

  83. VERBRUGGE FH, Martin AC, Siegal D, Pieper K, et al
    Impact of oral anticoagulation in patients with atrial fibrillation at very low thromboembolic risk.
    Heart. 2019 Dec 5. pii: heartjnl-2019-315873. doi: 10.1136/heartjnl-2019-315873.
    PubMed     Abstract available

    November 2019
  84. MIDDELDORP ME, Ariyaratnam J, Lau D, Sanders P, et al
    Lifestyle modifications for treatment of atrial fibrillation.
    Heart. 2019 Nov 11. pii: heartjnl-2019-315327. doi: 10.1136/heartjnl-2019-315327
    PubMed     Abstract available

  85. OTTO CM
    Heartbeat: sex differences in patient-reported outcomes with atrial fibrillation.
    Heart. 2019;105:1607-1609.

    October 2019
  86. STEINER JM, Bernacki G, Kirkpatrick J
    My guardian angel: patients' fears and desires related to discussing implantable cardioverter-defibrillator deactivation.
    Heart. 2019 Oct 31. pii: heartjnl-2019-315935. doi: 10.1136/heartjnl-2019-315935

  87. GOLDSWEIG A, Aronow HD
    Identifying patients likely to be readmitted after transcatheter aortic valve replacement.
    Heart. 2019 Oct 24. pii: heartjnl-2019-315381. doi: 10.1136/heartjnl-2019-315381
    PubMed     Abstract available

  88. XING L, Lin M, Du Z, Jing L, et al
    Epidemiology of atrial fibrillation in northeast China: a cross-sectional study, 2017-2019.
    Heart. 2019 Oct 13. pii: heartjnl-2019-315397. doi: 10.1136/heartjnl-2019-315397
    PubMed     Abstract available

  89. BANERJEE A, Benedetto V, Gichuru P, Burnell J, et al
    Adherence and persistence to direct oral anticoagulants in atrial fibrillation: a population-based study.
    Heart. 2019 Oct 10. pii: heartjnl-2019-315307. doi: 10.1136/heartjnl-2019-315307
    PubMed     Abstract available

  90. CHOU YL, Liou JT, Cheng CC, Tsai MC, et al
    The association of ischaemic stroke in patients with heart failure without atrial flutter/fibrillation.
    Heart. 2019 Oct 3. pii: heartjnl-2019-315646. doi: 10.1136/heartjnl-2019-315646.
    PubMed     Abstract available

    September 2019
  91. WU VC, Wu M, Aboyans V, Chang SH, et al
    Female sex as a risk factor for ischaemic stroke varies with age in patients with atrial fibrillation.
    Heart. 2019 Sep 26. pii: heartjnl-2019-315065. doi: 10.1136/heartjnl-2019-315065
    PubMed     Abstract available

  92. STOEVELAAR R, Brinkman-Stoppelenburg A, van Driel AG, van Bruchem-Visser RL, et al
    Implantable cardioverter defibrillator deactivation and advance care planning: a focus group study.
    Heart. 2019 Sep 19. pii: heartjnl-2019-315721. doi: 10.1136/heartjnl-2019-315721
    PubMed     Abstract available

  93. JAME S, Barnes G
    Stroke and thromboembolism prevention in atrial fibrillation.
    Heart. 2019 Sep 18. pii: heartjnl-2019-314898. doi: 10.1136/heartjnl-2019-314898
    PubMed     Abstract available

  94. AHN MS, Yoo BS, Yoon J, Lee SH, et al
    Guideline-directed therapy at discharge in patients with heart failure and atrial fibrillation.
    Heart. 2019 Sep 6. pii: heartjnl-2019-315240. doi: 10.1136/heartjnl-2019-315240.
    PubMed     Abstract available

  95. OTTO CM
    Heartbeat: Predictors of left atrial thrombus in patient with atrial fibrillation.
    Heart. 2019;105:1293-1294.

    August 2019
  96. WIJESURENDRA RS, Casadei B
    Mechanisms of atrial fibrillation.
    Heart. 2019 Aug 23. pii: heartjnl-2018-314267. doi: 10.1136/heartjnl-2018-314267
    PubMed     Abstract available

  97. ZHANG H, El-Am EA, Thaden JJ, Pislaru SV, et al
    Atrial fibrillation is not an independent predictor of outcome in patients with aortic stenosis.
    Heart. 2019 Aug 22. pii: heartjnl-2019-314996. doi: 10.1136/heartjnl-2019-314996
    PubMed     Abstract available

  98. FROEHLICH L, Meyre P, Aeschbacher S, Blum S, et al
    Left atrial dimension and cardiovascular outcomes in patients with and without atrial fibrillation: a systematic review and meta-analysis.
    Heart. 2019 Aug 17. pii: heartjnl-2019-315174. doi: 10.1136/heartjnl-2019-315174
    PubMed     Abstract available

  99. PERSSON AP, Fedorowski A, Hedblad B, Persson M, et al
    Heart rate and premature atrial contractions at 24hECG independently predict atrial fibrillation in a population-based study.
    Heart. 2019 Aug 12. pii: heartjnl-2019-315119. doi: 10.1136/heartjnl-2019-315119
    PubMed     Abstract available

    July 2019
  100. HENDRIKS J, Stromberg A
    Gender differences in atrial fibrillation: patient-reported outcomes beyond symptom management alone.
    Heart. 2019 Jul 11. pii: heartjnl-2019-315288. doi: 10.1136/heartjnl-2019-315288

    June 2019
  101. GLASS G, O'Connor R, Brady WJ
    Useful addition to acute myocardial infarction diagnosis in patients with left bundle branch block: an algorithm using electrocardiographic and biomarker analysis.
    Heart. 2019 Jun 27. pii: heartjnl-2019-315380. doi: 10.1136/heartjnl-2019-315380

  102. JONES NR, Taylor KS, Taylor CJ, Aveyard P, et al
    Weight change and the risk of incident atrial fibrillation: a systematic review and meta-analysis.
    Heart. 2019 Jun 22. pii: heartjnl-2019-314931. doi: 10.1136/heartjnl-2019-314931
    PubMed     Abstract available

  103. MALIK AH, Yandrapalli S, Aronow WS, Panza JA, et al
    Oral anticoagulants in atrial fibrillation with valvular heart disease and bioprosthetic heart valves.
    Heart. 2019 Jun 14. pii: heartjnl-2019-314767. doi: 10.1136/heartjnl-2019-314767
    PubMed     Abstract available

  104. TAN ESJ, Tay WT, Teng TK, Richards AM, et al
    The diabetes-atrial fibrillation paradox.
    Heart. 2019;105:893.

  105. OTTO CM
    Heartbeat: Diagnosis of subclinical atrial fibrillation by physicians and patients.
    Heart. 2019;105:809-811.

    May 2019
  106. FLORIA M, Tanase DM
    Atrial fibrillation type and renal dysfunction: new challenges in thromboembolic risk assessment.
    Heart. 2019 May 31. pii: heartjnl-2019-315212. doi: 10.1136/heartjnl-2019-315212

  107. NESTELBERGER T, Cullen L, Lindahl B, Reichlin T, et al
    Diagnosis of acute myocardial infarction in the presence of left bundle branch block.
    Heart. 2019 May 29. pii: heartjnl-2018-314673. doi: 10.1136/heartjnl-2018-314673
    PubMed     Abstract available

  108. GLEASON KT, Dennison Himmelfarb CR, Ford DE, Lehmann H, et al
    Association of sex and atrial fibrillation therapies with patient-reported outcomes.
    Heart. 2019 May 22. pii: heartjnl-2019-314881. doi: 10.1136/heartjnl-2019-314881
    PubMed     Abstract available

  109. TZEIS S, Asvestas D, Yen Ho S, Vardas P, et al
    Electrocardiographic landmarks of idiopathic ventricular arrhythmia origins.
    Heart. 2019 May 15. pii: heartjnl-2019-314748. doi: 10.1136/heartjnl-2019-314748
    PubMed     Abstract available

  110. INGRAHAM BS, Pislaru SV, Nkomo VT, Nishimura RA, et al
    Characteristics and treatment strategies for severe tricuspid regurgitation.
    Heart. 2019 May 15. pii: heartjnl-2019-314741. doi: 10.1136/heartjnl-2019-314741
    PubMed     Abstract available

    April 2019
  111. KAPLON-CIESLICKA A, Budnik M, Gawalko M, Peller M, et al
    Atrial fibrillation type and renal dysfunction as important predictors of left atrial thrombus.
    Heart. 2019 Apr 30. pii: heartjnl-2018-314492. doi: 10.1136/heartjnl-2018-314492
    PubMed     Abstract available

  112. ARBEL R, Sergienko R, Hammerman A, Dotan-Greenberg S, et al
    Direct oral anticoagulation and mortality in moderate to high-risk atrial fibrillation.
    Heart. 2019 Apr 10. pii: heartjnl-2018-314476. doi: 10.1136/heartjnl-2018-314476
    PubMed     Abstract available

  113. GALLAGHER C, Hendriks JM, Giles L, Karnon J, et al
    Increasing trends in hospitalisations due to atrial fibrillation in Australia from 1993 to 2013.
    Heart. 2019 Apr 1. pii: heartjnl-2018-314471. doi: 10.1136/heartjnl-2018-314471.
    PubMed     Abstract available

  114. EGBE AC, Miranda WR, Madhavan M, Ammash NM, et al
    Cardiac implantable electronic devices in adults with tetralogy of Fallot.
    Heart. 2019;105:538-544.
    PubMed     Abstract available

  115. WU KC, Zhang L, Haberlen SA, Ashikaga H, et al
    Predictors of electrocardiographic QT interval prolongation in men with HIV.
    Heart. 2019;105:559-565.
    PubMed     Abstract available

  116. KILLU AM, Stevenson WG
    Ventricular tachycardia in the absence of structural heart disease.
    Heart. 2019;105:645-656.

  117. SANDERS KH, Martin CA, Virdee M
    Sudden-onset severe presyncope in a 67-year-old man.
    Heart. 2019;105:657-659.
    PubMed     Abstract available

    March 2019
  118. POKORNEY SD, Lopes RD
    Atrial fibrillation: what do we know about screening and what do we not know about treatment?
    Heart. 2019 Mar 21. pii: heartjnl-2018-314518. doi: 10.1136/heartjnl-2018-314518

  119. SEJR MH, May O, Damgaard D, Sandal BF, et al
    External continuous ECG versus loop recording for atrial fibrillation detection in patients who had a stroke.
    Heart. 2019 Mar 21. pii: heartjnl-2018-314186. doi: 10.1136/heartjnl-2018-314186
    PubMed     Abstract available

  120. OTTO CM
    Heartbeat: Risk stratification for asymptomatic severe aortic stenosis.
    Heart. 2019;105:347-349.

    February 2019
  121. ERMAKOV S, Gulhar R, Lim L, Bibby D, et al
    Left ventricular mechanical dispersion predicts arrhythmic risk in mitral valve prolapse.
    Heart. 2019 Feb 12. pii: heartjnl-2018-314269. doi: 10.1136/heartjnl-2018-314269
    PubMed     Abstract available

  122. BURDEN AF, Timpson N
    Ethnicity, heart failure, atrial fibrillation and diabetes: collider bias.
    Heart. 2019 Feb 6. pii: heartjnl-2018-314467. doi: 10.1136/heartjnl-2018-314467.

    January 2019
  123. TAN ESJ, Tay WT, Teng TK, Sim D, et al
    Ethnic differences in atrial fibrillation in patients with heart failure from Asia-Pacific.
    Heart. 2019 Jan 19. pii: heartjnl-2018-314077. doi: 10.1136/heartjnl-2018-314077
    PubMed     Abstract available

  124. BEGG GA, Tayebjee MH
    Unusual fluoroscopic finding during atrial fibrillation cryoablation.
    Heart. 2019 Jan 19. pii: heartjnl-2018-314225. doi: 10.1136/heartjnl-2018-314225
    PubMed     Abstract available

    December 2018
  125. SBAROUNI E, Kogerakis N, Stavridis G
    68-year-old woman with paroxysmal atrial fibrillation.
    Heart. 2018 Dec 28. pii: heartjnl-2018-314143. doi: 10.1136/heartjnl-2018-314143
    PubMed     Abstract available

  126. HUANG CY, Lin LY
    Reply: further studies needed before using renin-angiotensin-aldosterone system blockade for atrial fibrillation prevention in hypertrophic cardiomyopathy.
    Heart. 2018;104:1985-1986.

  127. RAMCHAND J, Sampaio Rodrigues T, Yudi MB, Burrell LM, et al
    Further studies needed before using renin-angiotensin-aldosterone system blockade for atrial fibrillation prevention in hypertrophic cardiomyopathy.
    Heart. 2018;104:1985.

  128. ERWIN III J, Iung B
    Response to: 'Current recommendations for anticoagulant therapy in patients with valvular heart disease and atrial fibrillation: the ACC/AHA and ESC/EACTS Guidelines in Harmony...but not Lockstep!'
    Heart. 2018;104:2077.

  129. RIBEIRO AL, Otto CM
    Heartbeat: The worldwide burden of atrial fibrillation.
    Heart. 2018;104:1987-1988.

    Time to stop using 'non-valvular AF' inappropriately: letter in response to review article.
    Heart. 2018;104:2077.

  131. FIDALGO A, Fernandez-Friera L, Solis J
    A 52-year-old woman with ventricular tachycardia.
    Heart. 2018;104:2025-2043.
    PubMed     Abstract available

  132. DRAKOPOULOU M, Nashat H, Kempny A, Alonso-Gonzalez R, et al
    Arrhythmias in adult patients with congenital heart disease and pulmonary arterial hypertension.
    Heart. 2018;104:1963-1969.
    PubMed     Abstract available

  133. ALABED S, Providencia R, Chico TJA
    Cochrane corner: adenosine versus intravenous calcium channel antagonists for supraventricular tachycardia.
    Heart. 2018;104:1993-1994.

    November 2018
  134. NIEDERDOCKL J, Simon A, Schnaubelt S, Schuetz N, et al
    Cardiac biomarkers predict mortality in emergency patients presenting with atrial fibrillation.
    Heart. 2018 Nov 10. pii: heartjnl-2018-313145. doi: 10.1136/heartjnl-2018-313145
    PubMed     Abstract available

  135. KUPSKY DF, Ananthasubramaniam K, Lee J
    Eighty-two-year-old man with a systolic murmur.
    Heart. 2018;104:1887-1890.
    PubMed     Abstract available

  136. GROUTHIER V, Lebrun-Vignes B, Glazer AM, Touraine P, et al
    Increased long QT and torsade de pointes reporting on tamoxifen compared with aromatase inhibitors.
    Heart. 2018;104:1859-1863.
    PubMed     Abstract available

    October 2018
  137. BERNTSSON J, Smith JG, Johnson LSB, Soderholm M, et al
    Increased vascular endothelial growth factor D is associated with atrial fibrillation and ischaemic stroke.
    Heart. 2018 Oct 16. pii: heartjnl-2018-313684. doi: 10.1136/heartjnl-2018-313684
    PubMed     Abstract available

  138. HIJAZI Z, Wallentin L
    Natriuretic peptide should be used as a routine tool for evaluation of patients with atrial fibrillation.
    Heart. 2018 Oct 12. pii: heartjnl-2018-314040. doi: 10.1136/heartjnl-2018-314040

  139. GLOVER BM, Hong KL, Dagres N, Arbelo E, et al
    Impact of body mass index on the outcome of catheter ablation of atrial fibrillation.
    Heart. 2018 Oct 2. pii: heartjnl-2018-313490. doi: 10.1136/heartjnl-2018-313490.
    PubMed     Abstract available

    September 2018
  140. NTILOUDI D, Apostolopoulou S, Vasiliadis K, Frogoudaki A, et al
    Hospitalisations for heart failure predict mortality in pulmonary hypertension related to congenital heart disease.
    Heart. 2018 Sep 29. pii: heartjnl-2018-313613. doi: 10.1136/heartjnl-2018-313613
    PubMed     Abstract available

  141. INOHARA T, Kim S, Pieper K, Blanco RG, et al
    B-type natriuretic peptide, disease progression and clinical outcomes in atrial fibrillation.
    Heart. 2018 Sep 18. pii: heartjnl-2018-313642. doi: 10.1136/heartjnl-2018-313642
    PubMed     Abstract available

  142. CHRISTERSSON C, Wallentin L, Andersson U, Alexander JH, et al
    Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation.
    Heart. 2018 Sep 12. pii: heartjnl-2018-313351. doi: 10.1136/heartjnl-2018-313351
    PubMed     Abstract available

  143. CHOW CL, Abu Baker B, Mohamed U
    Pacing: a new look. Don't be deceived.
    Heart. 2018;104:1491-1528.
    PubMed     Abstract available

  144. BARRA S, Providencia R, Boveda S, Duehmke R, et al
    Device complications with addition of defibrillation to cardiac resynchronisation therapy for primary prevention.
    Heart. 2018;104:1529-1535.
    PubMed     Abstract available

    August 2018
  145. PETERS SAE, Woodward M
    Established and novel risk factors for atrial fibrillation in women compared with men.
    Heart. 2018 Aug 29. pii: heartjnl-2018-313630. doi: 10.1136/heartjnl-2018-313630
    PubMed     Abstract available

  146. HUANG W, Su L, Wu S, Xu L, et al
    Long-term outcomes of His bundle pacing in patients with heart failure with left bundle branch block.
    Heart. 2018 Aug 9. pii: heartjnl-2018-313415. doi: 10.1136/heartjnl-2018-313415.
    PubMed     Abstract available

  147. OTTO CM
    Heartbeat: Causes and consequences of atrial fibrillation.
    Heart. 2018;104:1229-1231.

  148. HUTCHINGS DC, Anderson SG, Caldwell JL, Trafford AW, et al
    Phosphodiesterase-5 inhibitors and the heart: compound cardioprotection?
    Heart. 2018;104:1244-1250.
    PubMed     Abstract available

  149. TONG C, Kiess M, Deyell MW, Qiu M, et al
    Impact of frequent premature ventricular contractions on pregnancy outcomes.
    Heart. 2018;104:1370-1375.
    PubMed     Abstract available

    July 2018
  150. SANDHU RK, Ezekowitz JA
    Is incentivising stroke prevention therapy in atrial fibrillation the key?
    Heart. 2018 Jul 10. pii: heartjnl-2018-313402. doi: 10.1136/heartjnl-2018-313402

  151. ADDERLEY NJ, Ryan R, Nirantharakumar K, Marshall T, et al
    Prevalence and treatment of atrial fibrillation in UK general practice from 2000 to 2016.
    Heart. 2018 Jul 10. pii: heartjnl-2018-312977. doi: 10.1136/heartjnl-2018-312977
    PubMed     Abstract available

  152. CALDEIRA D, Ferreira JJ, Pinto FJ, Costa J, et al
    Non-vitamin K antagonist oral anticoagulants and infective endocarditis.
    Heart. 2018;104:1135-1136.

  153. OTTO CM
    Heartbeat: cardiovascular disease risk and reproductive factors in women.
    Heart. 2018;104:1045-1047.

  154. HARRIS AW, Kudenchuk PJ
    Cardiopulmonary resuscitation: the science behind the hands.
    Heart. 2018;104:1056-1061.
    PubMed     Abstract available

  155. KUTTY S, Danford DA, Diller GP, Tutarel O, et al
    Contemporary management and outcomes in congenitally corrected transposition of the great arteries.
    Heart. 2018;104:1148-1155.
    PubMed     Abstract available

    June 2018
  156. HENDRIKS JM, Gallagher C, Middeldorp ME, Sanders P, et al
    New approaches to detection of atrial fibrillation.
    Heart. 2018 Jun 20. pii: heartjnl-2018-313423. doi: 10.1136/heartjnl-2018-313423

  157. PATEL NJ, Atti V, Mitrani RD, Viles-Gonzalez JF, et al
    Global rising trends of atrial fibrillation: a major public health concern.
    Heart. 2018 Jun 15. pii: heartjnl-2018-313350. doi: 10.1136/heartjnl-2018-313350

  158. DURHEIM MT, Holmes DN, Blanco RG, Allen LA, et al
    Characteristics and outcomes of adults with chronic obstructive pulmonary disease and atrial fibrillation.
    Heart. 2018 Jun 6. pii: heartjnl-2017-312735. doi: 10.1136/heartjnl-2017-312735.
    PubMed     Abstract available

  159. SEYERLE AA, Lin HJ, Gogarten SM, Stilp A, et al
    Genome-wide association study of PR interval in Hispanics/Latinos identifies novel locus at ID2.
    Heart. 2018;104:904-911.
    PubMed     Abstract available

  160. FRANCIS R, Lewis C
    Myocardial biopsy: techniques and indications.
    Heart. 2018;104:950-958.

  161. OTTO CM
    Heartbeat: socioeconomic deprivation is associated with non-cardiovascular mortality in chronic heart failure patients.
    Heart. 2018;104:961-963.

    May 2018
  162. POH MZ, Poh YC, Chan PH, Wong CK, et al
    Diagnostic assessment of a deep learning system for detecting atrial fibrillation in pulse waveforms.
    Heart. 2018 May 31. pii: heartjnl-2018-313147. doi: 10.1136/heartjnl-2018-313147
    PubMed     Abstract available

  163. BOKMA JP, Geva T, Sleeper LA, Babu Narayan SV, et al
    A propensity score-adjusted analysis of clinical outcomes after pulmonary valve replacement in tetralogy of Fallot.
    Heart. 2018;104:738-744.
    PubMed     Abstract available

    April 2018
  164. KIM D, Yang PS, Jang E, Yu HT, et al
    Increasing trends in hospital care burden of atrial fibrillation in Korea, 2006 through 2015.
    Heart. 2018 Apr 17. pii: heartjnl-2017-312930. doi: 10.1136/heartjnl-2017-312930
    PubMed     Abstract available

  165. LARSSON SC, Drca N, Bjorck M, Back M, et al
    Nut consumption and incidence of seven cardiovascular diseases.
    Heart. 2018 Apr 16. pii: heartjnl-2017-312819. doi: 10.1136/heartjnl-2017-312819
    PubMed     Abstract available

  166. WADIA SK, Lluri G, Aboulhosn JA, Shivkumar K, et al
    Ventricular arrhythmia burden after transcatheter versus surgical pulmonary valve replacement.
    Heart. 2018 Apr 10. pii: heartjnl-2017-312769. doi: 10.1136/heartjnl-2017-312769
    PubMed     Abstract available

  167. BISSON A, Bodin A, Fauchier L
    Why and how to screen for atrial fibrillation.
    Heart. 2018 Apr 5. pii: heartjnl-2018-313085. doi: 10.1136/heartjnl-2018-313085.

  168. LOWN M, Shah BN, Corbett SJ, Yue A, et al
    Response to: 'Screening for atrial fibrillation in hospitalised geriatric patients' by Tavernier et al.
    Heart. 2018;104:624.

  169. VIZZI V, Di Biasi M, Alessandrino G, Colombo A, et al
    Left atrial appendage occlusion in high-risk patients: doing it is better than nothing.
    Heart. 2018;104:625.

  170. MASOUD A, Bartoletti S, Fairbairn T, Khurana A, et al
    Outcome of left atrial appendage occlusion in high-risk patients.
    Heart. 2018;104:594-599.
    PubMed     Abstract available

    March 2018
  171. LINKER DT, Murphy TB, Mokdad AH
    Selective screening for atrial fibrillation using multivariable risk models.
    Heart. 2018 Mar 28. pii: heartjnl-2017-312686. doi: 10.1136/heartjnl-2017-312686
    PubMed     Abstract available

    Atrial fibrillation is target organ damage caused by an impaired haemodynamic state.
    Heart. 2018 Mar 24. pii: heartjnl-2017-312778. doi: 10.1136/heartjnl-2017-312778

  173. B SCHNABEL R, Pecen L, Engler D, Lucerna M, et al
    Atrial fibrillation patterns are associated with arrhythmia progression and clinical outcomes.
    Heart. 2018 Mar 17. pii: heartjnl-2017-312569. doi: 10.1136/heartjnl-2017-312569
    PubMed     Abstract available

  174. BETTENCOURT P, Lourenco P
    Atrial fibrillation, a difficulty in the heart failure screening with natriuretic peptides.
    Heart. 2018 Mar 16. pii: heartjnl-2017-312910. doi: 10.1136/heartjnl-2017-312910

  175. VAN DOORN S, Geersing GJ, Kievit RF, van Mourik Y, et al
    Opportunistic screening for heart failure with natriuretic peptides in patients with atrial fibrillation: a meta-analysis of individual participant data of four screening studies.
    Heart. 2018 Mar 16. pii: heartjnl-2017-312781. doi: 10.1136/heartjnl-2017-312781
    PubMed     Abstract available

  176. LAUNEY Y, Seguin P
    Is traumatic intracranial haemorrhage a specific risk factor for atrial fibrillation?
    Heart. 2018;104:450.

  177. WAGNER F, Gebauer RA, Paech C
    Newborn in cardiogenic shock.
    Heart. 2018;104:467.
    PubMed     Abstract available

    February 2018
  178. YUYUN MF, Squire IB, Ng GA, Samani NJ, et al
    Evidence for reduced susceptibility to cardiac bradycardias in South Asians compared with Caucasians.
    Heart. 2018 Feb 20. pii: heartjnl-2017-312374. doi: 10.1136/heartjnl-2017-312374
    PubMed     Abstract available

  179. IUNG B, Leenhardt A, Extramiana F
    Management of atrial fibrillation in patients with rheumatic mitral stenosis.
    Heart. 2018 Feb 16. pii: heartjnl-2017-311425. doi: 10.1136/heartjnl-2017-311425
    PubMed     Abstract available

  180. TIKHONOFF V, Kuznetsova T, Thijs L, Cauwenberghs N, et al
    Ambulatory blood pressure and long-term risk for atrial fibrillation.
    Heart. 2018 Feb 9. pii: heartjnl-2017-312488. doi: 10.1136/heartjnl-2017-312488.
    PubMed     Abstract available

  181. COWIE MR, Zakeri R
    Preventing stroke in patients with heart failure: why are patients losing out?
    Heart. 2018 Feb 2. pii: heartjnl-2017-312862. doi: 10.1136/heartjnl-2017-312862.

  182. HAWKINS NM, Grubisic M, Andrade JG, Huang F, et al
    Long-term complications, reoperations and survival following cardioverter-defibrillator implant.
    Heart. 2018;104:237-243.
    PubMed     Abstract available

  183. MANGLA A, Bjorklund JK, Kalra DK
    An unusual echo after ventricular tachycardia ablation.
    Heart. 2018;104:359-360.

    January 2018
  184. HUANG CY, Yang YH, Lin LY, Tsai CT, et al
    Renin-angiotensin-aldosterone blockade reduces atrial fibrillation in hypertrophic cardiomyopathy.
    Heart. 2018 Jan 25. pii: heartjnl-2017-312573. doi: 10.1136/heartjnl-2017-312573
    PubMed     Abstract available

  185. SAVARESE G, Sartipy U, Friberg L, Dahlstrom U, et al
    Reasons for and consequences of oral anticoagulant underuse in atrial fibrillation with heart failure.
    Heart. 2018 Jan 25. pii: heartjnl-2017-312720. doi: 10.1136/heartjnl-2017-312720
    PubMed     Abstract available

  186. AKOUM N
    Persistently high incidence of postcoronary bypass atrial fibrillation: possible mechanisms.
    Heart. 2018 Jan 19. pii: heartjnl-2017-312627. doi: 10.1136/heartjnl-2017-312627

  187. VINEREANU D, Wang A, Mulder H, Lopes RD, et al
    Outcomes in anticoagulated patients with atrial fibrillation and with mitral or aortic valve disease.
    Heart. 2018 Jan 19. pii: heartjnl-2017-312272. doi: 10.1136/heartjnl-2017-312272
    PubMed     Abstract available

  188. FILARDO G, Damiano RJ Jr, Ailawadi G, Thourani VH, et al
    Epidemiology of new-onset atrial fibrillation following coronary artery bypass graft surgery.
    Heart. 2018 Jan 11. pii: heartjnl-2017-312150. doi: 10.1136/heartjnl-2017-312150
    PubMed     Abstract available

  189. ERWIN JP 3RD, Iung B
    Current recommendations for anticoagulant therapy in patients with valvular heart disease and atrial fibrillation: the ACC/AHA and ESC/EACTS Guidelines in Harmony...but not Lockstep!
    Heart. 2018 Jan 11. pii: heartjnl-2017-312758. doi: 10.1136/heartjnl-2017-312758

  190. ALONSO A, MacLehose RF, Chen LY, Bengtson LGS, et al
    Oral anticoagulants and liver injury: the threat of uncontrolled confounding.
    Heart. 2018;104:84.

    December 2017
  191. SIONTIS GCM, Praz F, Lanz J, Vollenbroich R, et al
    New-onset arrhythmias following transcatheter aortic valve implantation: a systematic review and meta-analysis.
    Heart. 2017 Dec 23. pii: heartjnl-2017-312310. doi: 10.1136/heartjnl-2017-312310
    PubMed     Abstract available

  192. OTTO CM
    Heartbeat: Healthcare approaches to reducing adverse outcomes in patients with atrial fibrillation.
    Heart. 2017;103:1925-1927.

  193. MARTENS P, Verbrugge FH, Nijst P, Dupont M, et al
    Incremental benefit of cardiac resynchronisation therapy with versus without a defibrillator.
    Heart. 2017;103:1977-1984.
    PubMed     Abstract available

    November 2017
  194. BORIANI G, Proietti M
    Atrial fibrillation prevention: an appraisal of current evidence.
    Heart. 2017 Nov 30. pii: heartjnl-2017-311546. doi: 10.1136/heartjnl-2017-311546
    PubMed     Abstract available

  195. PATTI G
    Patients with atrial fibrillation and coronary events: are we any closer to coming out from the labyrinth of the various antithrombotic strategies?
    Heart. 2017 Nov 25. pii: heartjnl-2017-312576. doi: 10.1136/heartjnl-2017-312576

  196. SINDET-PEDERSEN C, Staerk L, Lamberts M, Gerds TA, et al
    Use of oral anticoagulants in combination with antiplatelet(s) in atrial fibrillation.
    Heart. 2017 Nov 1. pii: heartjnl-2017-311976. doi: 10.1136/heartjnl-2017-311976.
    PubMed     Abstract available

  197. LAZZERINI PE, Laghi-Pasini F, Bertolozzi I, Morozzi G, et al
    Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes.
    Heart. 2017;103:1821-1829.
    PubMed     Abstract available

    October 2017
  198. CORTIGIANI L, Carpeggiani C, Sicari R, Michelassi C, et al
    Simple six-item clinical score improves risk prediction capability of stress echocardiography.
    Heart. 2017 Oct 14. pii: heartjnl-2017-312122. doi: 10.1136/heartjnl-2017-312122
    PubMed     Abstract available

  199. WONG JA, Rexrode KM, Sandhu RK, Moorthy MV, et al
    Menopausal age, postmenopausal hormone therapy and incident atrial fibrillation.
    Heart. 2017 Oct 7. pii: heartjnl-2016-311002. doi: 10.1136/heartjnl-2016-311002.
    PubMed     Abstract available

  200. MARTIN CA, Gajendragadkar PR, Agarwal S
    Palpitations in a 72-year-old woman.
    Heart. 2017;103:1554-1555.
    PubMed     Abstract available

  201. MARTIN CA, Lambiase PD
    Pathophysiology, diagnosis and treatment of tachycardiomyopathy.
    Heart. 2017;103:1543-1552.

    September 2017
  202. PROVIDENCIA R, Karim N, Srinivasan N, Honarbakhsh S, et al
    Impact of QTc formulae in the prevalence of short corrected QT interval and impact on probability and diagnosis of short QT syndrome.
    Heart. 2017 Sep 27. pii: heartjnl-2017-311673. doi: 10.1136/heartjnl-2017-311673
    PubMed     Abstract available

  203. LIU K, Ahmed J, Feiglin D
    A 54-year-old man with new-onset ventricular fibrillation.
    Heart. 2017 Sep 27. pii: heartjnl-2017-312052. doi: 10.1136/heartjnl-2017-312052
    PubMed     Abstract available

  204. BAPAT A, Anderson CD, Ellinor PT, Lubitz SA, et al
    Genomic basis of atrial fibrillation.
    Heart. 2017 Sep 11. pii: heartjnl-2016-311027. doi: 10.1136/heartjnl-2016-311027
    PubMed     Abstract available

  205. TAVERNIER R, Wolf M, Kataria V, Phlips T, et al
    Screening for atrial fibrillation in hospitalised geriatric patients.
    Heart. 2017 Sep 7. pii: heartjnl-2017-311981. doi: 10.1136/heartjnl-2017-311981.
    PubMed     Abstract available

  206. RAOUF WA, Shams K, Mansour A
    An unusual cause of tachyarrhythmia in an otherwise healthy young man.
    Heart. 2017;103:1472.
    PubMed     Abstract available

  207. HONARBAKHSH S, Baker V, Kirkby C, Patel K, et al
    Safety and efficacy of paramedic treatment of regular supraventricular tachycardia: a randomised controlled trial.
    Heart. 2017;103:1413-1418.
    PubMed     Abstract available

  208. ZUMHAGEN S, Vrachimis A, Stegger L, Kies P, et al
    Impact of presynaptic sympathetic imbalance in long-QT syndrome by positron emission tomography.
    Heart. 2017 Sep 1. pii: heartjnl-2017-311667. doi: 10.1136/heartjnl-2017-311667.
    PubMed     Abstract available

  209. BROUGH C
    Expediting the pathway to supraventricular tachycardia ablation.
    Heart. 2017;103:1471.

  210. MCLEOD CJ
    Acute arrhythmias in adults with congenital heart disease.
    Heart. 2017;103:1380-1388.

    August 2017
  211. BHAVE PD
    What do our patients think they know about atrial fibrillation? ... Is that asking the right question?
    Heart. 2017 Aug 16. pii: heartjnl-2017-312124. doi: 10.1136/heartjnl-2017-312124

  212. KAUFMAN BG, Kim S, Pieper K, Allen LA, et al
    Disease understanding in patients newly diagnosed with atrial fibrillation.
    Heart. 2017 Aug 8. pii: heartjnl-2017-311800. doi: 10.1136/heartjnl-2017-311800.
    PubMed     Abstract available

  213. GUHL EN, Magnani JW
    Atrial fibrillation and menopause: something else to worry about, or not?
    Heart. 2017 Aug 5. pii: heartjnl-2017-311771. doi: 10.1136/heartjnl-2017-311771.

  214. OTTO CM
    Heartbeat: Chocolate and atrial fibrillation.
    Heart. 2017;103:1139-1140.

  215. GOUDA P, Veenhuyzen G, Har B
    Fifty-year-old woman with lightheadedness.
    Heart. 2017;103:1224.

    July 2017
  216. CHUE CD, Kwok CS, Wong CW, Patwala A, et al
    Efficacy and safety of the subcutaneous implantable cardioverter defibrillator: a systematic review.
    Heart. 2017 Jul 7. pii: heartjnl-2016-310852. doi: 10.1136/heartjnl-2016-310852.
    PubMed     Abstract available

  217. STEWART S
    Bringing order to chaos: the case for integrated management of atrial fibrillation.
    Heart. 2017 Jul 6. pii: heartjnl-2017-311519. doi: 10.1136/heartjnl-2017-311519.

  218. RYDMAN R, Shiina Y, Diller GP, Niwa K, et al
    Major adverse events and atrial tachycardia in Ebstein's anomaly predicted by cardiovascular magnetic resonance.
    Heart. 2017 Jul 6. pii: heartjnl-2017-311274. doi: 10.1136/heartjnl-2017-311274.
    PubMed     Abstract available

    June 2017
  219. GHANNAM M, Chugh A
    Indications and appropriate selection of novel oral anticoagulants in patients with atrial fibrillation.
    Heart. 2017 Jun 17. pii: heartjnl-2014-307030. doi: 10.1136/heartjnl-2014-307030

  220. ISAEW A, Adderley NJ, Ryan R, Fitzmaurice D, et al
    The treatment of paroxysmal atrial fibrillation in UK primary care.
    Heart. 2017 Jun 1. pii: heartjnl-2016-310927. doi: 10.1136/heartjnl-2016-310927.
    PubMed     Abstract available

  221. BROENDBERG AK, Nielsen JC, Bjerre J, Pedersen LN, et al
    Nationwide experience of catecholaminergic polymorphic ventricular tachycardia caused by RyR2 mutations.
    Heart. 2017;103:901-909.
    PubMed     Abstract available

  222. LIEW AC, Raphael CE, Mohiaddin R
    A 38-year-old man with progressive dyspnoea and ventricular tachycardia.
    Heart. 2017;103:839.
    PubMed     Abstract available

    Catecholaminergic polymorphic tachycardia: underestimated and overtreated?
    Heart. 2017;103:889-890.

  224. POTPARA TS, Lip GY
    Drug-induced liver injury with oral anticoagulants: a threat or not?
    Heart. 2017;103:809-811.

  225. WATSON W, Ring L, Salahshouri P
    84-year-old woman with dizziness.
    Heart. 2017;103:966.

  226. HENEGHAN CJ, Spencer EA, Mahtani KR
    Cochrane corner: self-monitoring and self-management of oral anticoagulation.
    Heart. 2017;103:895-896.

    May 2017
  227. MOSTOFSKY E, Berg Johansen M, Tjonneland A, Chahal HS, et al
    Chocolate intake and risk of clinically apparent atrial fibrillation: the Danish Diet, Cancer, and Health Study.
    Heart. 2017 May 23. pii: heartjnl-2016-310357. doi: 10.1136/heartjnl-2016-310357
    PubMed     Abstract available

  228. POKORNEY SD, Piccini JP
    Chocolate and prevention of atrial fibrillation: what is bad for the pancreas might be good for the atria?
    Heart. 2017 May 23. pii: heartjnl-2016-311026. doi: 10.1136/heartjnl-2016-311026

  229. GALLAGHER C, Elliott AD, Wong CX, Rangnekar G, et al
    Integrated care in atrial fibrillation: a systematic review and meta-analysis.
    Heart. 2017 May 10. pii: heartjnl-2016-310952. doi: 10.1136/heartjnl-2016-310952
    PubMed     Abstract available

  230. BOKMA JP, Winter MM, Vehmeijer JT, Vliegen HW, et al
    QRS fragmentation is superior to QRS duration in predicting mortality in adults with tetralogy of Fallot.
    Heart. 2017;103:666-671.
    PubMed     Abstract available

  231. VON ROTZ M, Aeschbacher S, Bossard M, Schoen T, et al
    Risk factors for premature ventricular contractions in young and healthy adults.
    Heart. 2017;103:702-707.
    PubMed     Abstract available

  232. HENG EL, Gatzoulis MA
    QRS fragmentation in tetralogy of Fallot: clinical utility and risk prediction.
    Heart. 2017;103:645-646.

    April 2017
  233. POTPARA TS, Blomstrom-Lundqvist C
    Sex-related differences in atrial fibrillation: can we discern true disparities from biases?
    Heart. 2017 Apr 29. pii: heartjnl-2016-311085. doi: 10.1136/heartjnl-2016-311085

  234. MINAMI Y, Hagiwara N
    Enlarged left atrium, atrial fibrillation and adverse outcome in hypertrophic cardiomyopathy: is there a difference between apical and non-apical phenotype?
    Heart. 2017 Apr 28. pii: heartjnl-2017-311501. doi: 10.1136/heartjnl-2017-311501

  235. LEE SE, Park JK, Uhm JS, Kim JY, et al
    Impact of atrial fibrillation on the clinical course of apical hypertrophic cardiomyopathy.
    Heart. 2017 Apr 20. pii: heartjnl-2016-310720. doi: 10.1136/heartjnl-2016-310720
    PubMed     Abstract available

  236. LIN WS, Lin TC, Hung Y, Lin WY, et al
    Traumatic intracranial haemorrhage is in association with an increased risk of subsequent atrial fibrillation.
    Heart. 2017 Apr 7. pii: heartjnl-2016-310451. doi: 10.1136/heartjnl-2016-310451.
    PubMed     Abstract available

  237. HENDRIKS JM, Gallagher C, Sanders P
    Ensuring adherence to therapy with anticoagulation in patients with atrial fibrillation.
    Heart. 2017 Apr 7. pii: heartjnl-2017-311305. doi: 10.1136/heartjnl-2017-311305.

  238. YEO C, Tan VH, Wong KC
    Exercise-induced syncope in a 22-year-old man.
    Heart. 2017;103:642.
    PubMed     Abstract available

  239. AMBALE-VENKATESH B, Yoneyama K, Sharma RK, Ohyama Y, et al
    Left ventricular shape predicts different types of cardiovascular events in the general population.
    Heart. 2017;103:499-507.
    PubMed     Abstract available

    March 2017
  240. BENOIST D, Dubes V, Roubertie F, Gilbert SH, et al
    Proarrhythmic remodelling of the right ventricle in a porcine model of repaired tetralogy of Fallot.
    Heart. 2017;103:347-354.
    PubMed     Abstract available

  241. HAGNAS MJ, Lakka TA, Kurl S, Rauramaa R, et al
    Cardiorespiratory fitness and exercise-induced ST segment depression in assessing the risk of sudden cardiac death in men.
    Heart. 2017;103:383-389.
    PubMed     Abstract available

    January 2017
  242. OTTO CM
    Heartbeat: Left atrial appendage occlusion for stroke prevention.
    Heart. 2017;103:89-90.

    August 2016
  243. CUYPERS JA, Menting ME, Opic P, Utens EM, et al
    The unnatural history of pulmonary stenosis up to 40 years after surgical repair.
    Heart. 2016 Aug 11. pii: heartjnl-2015-309159. doi: 10.1136/heartjnl-2015-309159
    PubMed     Abstract available

    June 2016
  244. DHILLON A, Khanna A, Randhawa MS, Cywinski J, et al
    Perioperative outcomes of patients with hypertrophic cardiomyopathy undergoing non-cardiac surgery.
    Heart. 2016 Jun 10. pii: heartjnl-2016-309442. doi: 10.1136/heartjnl-2016-309442
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.